Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
Autor: | Taniguchi, Toshibumi, Homma, Tomoyuki, Tamai, Yoichi, Arita, Yoshifumi, Fujiwara, Masakazu, Kuroishi, Naho, Sugiyama, Keiji, Kanazu, Shinichi, Maruyama, Atsushi |
---|---|
Zdroj: | In Journal of Infection and Chemotherapy July 2024 |
Databáze: | ScienceDirect |
Externí odkaz: |